Prostate-specific membrane antigen (PSMA) is a transmembrane glycoprotein that is highly overexpressed in prostate cancer cells, particularly in advanced and metastatic stages, while exhibiting limited expression in normal tissues (32, 33). Here, FOLH1 is linked to prostate cancer.